Search keyWord :

China Yuchai International Announces Unaudited 2024 Second Half-Year and Full Year Financial Results

Feb 26, 2025

SINGAPORE,Feb. 25,2025-- China Yuchai International Limited(NYSE: CYD) ("China Yuchai" or the "Company"),one of the largest powertrain solution manufacturers through its main opera

Kerry Establishes Local Manufacturing Partnership for Taste Solutions in Pakistan

Feb 26, 2025

KARACHI,Pakistan,Feb. 25,2025--Kerry,a global leader in taste and nutrition,has partnered with Far Eastern Impex (FEI) to open the first international production operation for flavourings in Pakistan

WuXi XDC and LigaChem Biosciences Strengthen Partnership with Expanded MOU to Accelerate ADC Development

Feb 26, 2025

SHANGHAI,Feb. 25,2025-- WuXi XDC Cayman Inc. ("WuXi XDC",or the "Company",stock code: 2268.HK),a leading global CRDMO (Contract Research,Development,and Manufacturing Organization)

Everest Medicines to Announce Full-Year 2024 Financial Results on March 26, 2025

Feb 26, 2025

SHANGHAI,Feb. 25,2025-- Everest Medicines (HKEX 1952.HK,"Everest",or the "Company"),a biopharmaceutical company focused on the discovery,clinical development,manufacturing and comm

HUYA Inc. to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Tuesday, March 18, 2025

Feb 26, 2025

-Earnings Webinar Scheduled for 6:00 a.m. ET on March 18,2025- GUANGZHOU,China,Feb. 25,2025--HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA),a leading game live streaming platform

teamLab Phenomena Abu Dhabi Will Open on 18 April Within Saadiyat Cultural District Abu Dhabi

Feb 26, 2025

ABU DHABI,UAE,Feb. 25,2025--teamLab Phenomena Abu Dhabiwill officially open its doors to the public in Saadiyat Cultural District Abu Dhabi on 18 April 2025,announced by the Department of Culture and

MicuRx Pharmaceutical: Contezolid Global Phase III Clinical Trial Safety and Efficacy Evaluation Endorsed by Data Monitoring Committee, Promising Prospects for Diabetic Foot Infection Treatment

Feb 26, 2025

Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial,recommending continued progression as planned

Sino Land Recognised in CDP's 2024 'A List' for Corporate Sustainability Leadership in Climate Action

Feb 26, 2025

HONG KONG,Feb. 25,2025--Sino Group(\'the Group\') is pleased to announce that Sino Land Company Limited (\'Sino Land\') (Stock Code: 0083.HK) has been recognised as one of the first developers in Hong

Innovation and technology fuels winter economy in Harbin

Feb 26, 2025

BEIJING,Feb. 25,2025-- A news report from China Daily: Harbin,capital of Heilongjiang province in Northeast China,has become a popular destination for ice and snow tourism in recent years.

KT&G to Hold 38th Annual General Meeting

Feb 26, 2025

- Annual General Meeting on Mar. 26th,agendas include director appointment SEOUL,South Korea,Feb. 25,2025-- KT&G Corporation ("KT&G" or the "Company") (KRX:033780) held a

1 ... 285 286 287 288 289 290 291 ... 1258